Detalles de la búsqueda
1.
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World.
Oncologist
; 2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38520745
2.
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50.
Cancer Immunol Immunother
; 69(11): 2209-2221, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32474768
3.
MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiforme.
Future Oncol
; 14(8): 699-707, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29521523
4.
Treatment of lung large cell neuroendocrine carcinoma.
Tumour Biol
; 37(6): 7047-57, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26943800
5.
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research.
Clin Lung Cancer
; 25(2): 190-195, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38262770
6.
Rare and Insidious Toxicities from New Combination Therapies in Metastatic Renal Cell Cancer: Lessons Learned from Real-Practice.
Curr Oncol
; 29(10): 6776-6786, 2022 09 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36290810
7.
Host immune-inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD-L1 ≥50% metastatic non-small cell lung cancer and poor performance status receiving first-line immunotherapy.
Thorac Cancer
; 13(3): 483-488, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34939342
8.
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status.
J Hematol Oncol
; 15(1): 9, 2022 01 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35062993
9.
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy.
J Immunother Cancer
; 9(4)2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33827906
10.
Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World.
Drugs Aging
; 37(9): 677-689, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32681401
11.
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial).
Ther Adv Med Oncol
; 12: 1758835920915983, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32733604
12.
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non-small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy.
Clin Lung Cancer
; 21(1): 1-14.e3, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31601525
13.
Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes.
Clin Lung Cancer
; 21(6): 498-508.e2, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32680806
14.
KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC.
Ther Adv Med Oncol
; 11: 1758835919885540, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31798692
15.
Italian Nivolumab Expanded Access Program in Nonsquamous Non-Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients.
J Thorac Oncol
; 13(8): 1146-1155, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29730379
16.
Small-Cell Lung Cancer: Clinical Management and Unmet Needs New Perspectives for an Old Problem.
Curr Drug Targets
; 18(3): 341-362, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-27138756
17.
Can the response to a platinum-based therapy be predicted by the DNA repair status in non-small cell lung cancer?
Cancer Treat Rev
; 48: 8-19, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27262017
18.
Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the future.
Transl Lung Cancer Res
; 5(6): 563-578, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28149752
19.
Thymoma and thymic carcinomas.
Crit Rev Oncol Hematol
; 99: 332-50, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26818050
20.
Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy?
Tumori
; 102(1): 18-30, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26481865